Literature DB >> 18041385

Helicobacter pylori infection and coronary artery disease.

Aleksandar Vcev1, Dario Nakić, Anamarija Mrden, Jure Mirat, Sanja Balen, Alen Ruzić, Viktor Persić, Ivan Soldo, Marko Matijević, Jerko Barbić, Valentina Matijević, Dubravko Bozić, Branko Radanović.   

Abstract

The aim of this investigation was to determine the seroprevalence of H. pylori in patients with coronary artery disease (CAD). Patients with coronary artery disease (n = 90) and control group (n = 90) were enrolled into this randomized, multi-centre study. CAD risk factors analyzed included age, male gender, diabetes mellitus, systemic hypertension, cigarette smoking, hypercholesterolemia and socioeconomic status. The results of this study showed a higher seroprevalence of Helicobacter pylori infection in patients with CAD compared to controls (78.8% versus 58.3%, p < 0.05). However, Helicobacter pylori seropositivity was not associated with coronary artery risk factors (smoking, body mass index, diabetes mellitus, hypertension, total cholesterol and socioeconomic status) either in the whole study population or in the patients and control subjects analyzed separately (P > 0.05). Further study are needed to clarify the precise role of Helicobacter pylori infection on the development of coronary artery disease.

Entities:  

Mesh:

Year:  2007        PMID: 18041385

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  14 in total

Review 1.  Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Authors:  Jacek Budzyński; Joanna Wiśniewska; Marek Ciecierski; Anna Kędzia
Journal:  Int J Angiol       Date:  2015-03-23

2.  Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A meta-analysis.

Authors:  Xin-Juan Yu; Xuan Yang; Lei Feng; Li-Li Wang; Quan-Jiang Dong
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

Review 3.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

Review 4.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

5.  Effect of minocycline postconditioning and ischemic postconditioning on myocardial ischemia-reperfusion injury in atherosclerosis rabbits.

Authors:  Conggang Huang; Rui Li; Qiutang Zeng; Yanping Ding; Yongguang Zou; Xiaobo Mao; Wei Hu; Rong Xiong; Ming Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

6.  Blood pressure and stature in Helicobacter pylori positive and negative persons.

Authors:  Marcela Kopacova; Ilona Koupil; Bohumil Seifert; Miluska Skodova Fendrichova; Jana Spirkova; Viktor Vorisek; Stanislav Rejchrt; Tomas Douda; Ilja Tacheci; Jan Bures
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 7.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

8.  Helicobacter pylori seropositivity in patients with acute coronary syndromes.

Authors:  Gulden S Tamer; Istemihan Tengiz; Ertugrul Ercan; Can Duman; Emin Alioglu; Ugur O Turk
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

9.  Antibiotics for secondary prevention of coronary heart disease.

Authors:  Naqash J Sethi; Sanam Safi; Steven Kwasi Korang; Asbjørn Hróbjartsson; Maria Skoog; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

Review 10.  Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact?

Authors:  Waleed I Albaker
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.